Skip to main content

Clinical Overview: Diagnosis and Management

  • Chapter
  • First Online:
Lymphedema
  • 2804 Accesses

Abstract

There are about 120 million people at risk for and 70 million people who have established lymphatic filariasis, of which 40 million are suffering from lymphedema; thus, it is very important for medical, paramedic, and health planners to understand this disease and to provide morbidity control including surgery for these unfortunate patients. The World Health Organization is working toward elimination of lymphatic filariasis by 2020.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

Highlighted References

  1. Dreyer G, Figueredo-Silva J, Carvalho K, Amaral F, Ottesen EA. Lymphatic filariasis in children: adenopathy and its evolution in two young girls. Am J Trop Med Hyg. 2001;65:204–7. PubMed.

    Article  CAS  PubMed  Google Scholar 

  2. Schlemper BR, Steindel M, Grisard EC, Carvalho-Pinto CJ, Bernardini OJ, et al. Elimination of bancroftianfilariasis (Wuchereriabancrofti) in Santa Catarina state, Brazil. Tropical Med Int Health. 2000;5:848–54. PubMedCrossRef.

    Article  Google Scholar 

  3. Bockarie MJ, Ibam E, Alexander NDE, Hyun P, Dimber Z, et al. Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereriabancrofti in East Sepik Province. P N G Med J. 2000;43:172–82.

    CAS  PubMed  Google Scholar 

  4. Grady CA, de Rochars MB, Direny AN, Orelus JN, Wendt J, et al. Endpoints for lymphatic filariasis programs. Emerg Infect Dis. 2007;13:608–10. CrossRef.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Chhotray GP, Ranjit MR, Mohapatra M. Occurrence of asymptomatic microscopic haematuria in a filarial endemic area of Orissa, India. J Commun Dis. 2000;32:85–93. PubMed.

    CAS  PubMed  Google Scholar 

References

  1. Molyneux DH, Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol. 2002;96:S15–40. PubMedCrossRef.

    Article  PubMed  Google Scholar 

  2. Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the elimination of lymphatic filariasis. Bull World Health Organ. 1997;75:491–503. PubMed.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Ottesen EA. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol. 2006;61:395–441. PubMedCrossRef.

    Article  PubMed  Google Scholar 

  4. World Health Organization. Global programme to eliminate lymphatic filariasis: progress report for 2004. Wkly Epidemiol Rec. 2005;80:202–12.

    Google Scholar 

  5. World Health Organization. Global programme to eliminate lymphatic filariasis: progress report on mass drug administrations in 2005. Wkly Epidemiol Rec. 2006;22:221–32.

    Google Scholar 

  6. World Health Organization. Global programme to eliminate lymphatic filariasis: progress report on mass drug administration in 2006. Wkly Epidemiol Rec. 2007;82:361–80.

    Google Scholar 

  7. World Health Organization. Global programme to eliminate lymphatic filariasis: progress report on mass drug administration in 2007. Wkly Epidemiol Rec. 2008;83:333–48.

    Google Scholar 

  8. World Health Organization. Annual report on lymphatic Filariasis 2001. Geneva; 2002. http://whqlibdoc.who.int/hq/2002/WHO_CDS_CPE_CEE_2002.28.pdf.

  9. World Health Organization. Annual report on lymphatic Filariasis 2002. Geneva; 2003. http://whqlibdoc.who.int/hq/2003/WHO_CDS_CPE_CEE_2003.38.pdf.

  10. World Health Organization. Annual report on lymphatic Filariasis 2003. Geneva; 2004. http://whqlibdoc.who.int/hq/2005/WHO_CDS_CPE_CEE_2005.52.pdf.

  11. Dreyer G, Ottesen EA, Galdino E, Andrade L, Rocha A, et al. Renal abnormalities in microfilaremic patients with Bancroftianfilariasis. Am J Trop Med Hyg. 1992;46:745–51. PubMed.

    Article  CAS  PubMed  Google Scholar 

  12. Dreyer G, Addiss D, Dreyer P, Noroes J. Basic lymphedema management: treatment and prevention of problems associated with lymphatic Filariasis. Hollis: Hollis Publishing Company; 2002.

    Google Scholar 

  13. Ottesen EA. Infection and disease in lymphatic filariasis: an immunological perspective. Parasitology. 1992;104:S71–9. PubMedCrossRef.

    Article  PubMed  Google Scholar 

  14. Freedman DO, de Almeida Filho PJ, Besh S, et al. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis. 1994;170:927–33. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  15. Noroes J, Addis D, Amaral F, et al. Occurrence of living adult Wuchereriabancrofti in the scrotal area of men with microfilaremia. Trans R Soc Trop Med Hyg. 1996;90:55–6. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  16. Pani SP, Yuvaraj J, Vanamail D, et al. Episodic adenolymphangitis and lymphoedema in patients with bancroftianfilariasis. Trans R Soc Trop Med Hyg. 1992;89:72–4. CrossRef.

    Article  Google Scholar 

  17. Ottesen EA, Nutman TB. Tropical pulmonary eosinophilia. Annu Rev Med. 1992;43:417–24. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  18. Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol. 2003;19(11):516–22. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  19. Bosshardt SC, et al. Prophylactic activity of tetracycline against Brugiapahangi infection in jirds (Merionesunguiculatus). J Parasitol. 1993;79:775–7. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  20. McCall JW, et al. Wolbachia and the antifilarial properties of tetracycline.An untold story. Ital J Zool. 1999;66:7–10. CrossRef.

    Article  Google Scholar 

  21. Bandi C, et al. Effects of tetracycline on the filarial worms Brugiapahangi and Dirofilariaimmitis and their bacterial endosymbionts Wolbachia. Int J Parasitol. 1999;29:357–64. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  22. Hoerauf A, et al. Targeting of Wolbachia in Litomosoides sigmodontis: comparison of tetracycline with chloramphenicol, macrolides and ciprofloxacin. Tropical Med Int Health. 2000;5(4):275–9.

    Article  CAS  Google Scholar 

  23. Townson S, et al. The activity of rifampicin, oxytetracycline and chloramphenicol against Onchocercalienalis and O. gutturosa. Trans R Soc Trop Med Hyg. 1999;93:123–4.

    Google Scholar 

  24. Schuetz A, Addiss DG, Eberhard ML, Lammie PJ. Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment. Am J Trop Med Hyg. 2000;62(4):502–3. PubMed.

    Article  CAS  PubMed  Google Scholar 

  25. Weil GJ, Lammie PJ, Weiss N. The ICT Filariasis test: a rapid-format antigen test for diagnosis of bancroftianfilariasis. Parasitol Today. 1997;13(10):401–4. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  26. Amaral F, Dreyer G, Figueredo-Silva J, et al. Live adult worms detected by ultrasonography in human Bancroftianfilariasis. Am J Trop Med Hyg. 1994;50:753–7. PubMed.

    Article  CAS  PubMed  Google Scholar 

  27. Dreyer G, Santos A, Noroes J, Amaral F, Addiss D. Ultrasonographic detection of living adult Wuchereriabancrofti using a 3.5-MHz transducer. Am J Trop Med Hyg. 1998;59:399–403. PubMed.

    Article  CAS  PubMed  Google Scholar 

  28. Homeida MA, Mackenzie CD, Williams JF, Ghalib HW. The detection of onchocercal nodules by ultrasound technique. Trans R Soc Trop Med Hyg. 1986;80:570–1. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  29. Leichsenring M, Troger J, Nelle M, Buttner DW, Darge K, Doehring-Schwerdtfeger E. Ultrasonographical investigations of onchocerciasis in Liberia. Am J Trop Med Hyg. 1990;43:380–5. PubMed.

    Article  CAS  PubMed  Google Scholar 

  30. Shelley S, Manokaran G, Indirani M, Gokhale S, Anirudhan N. Lymphoscintigraphy as a diagnostic tool in patients with lymphedema of filarial origin—an Indian study. Lymphology. 2006;39(2):69–75. PubMed.

    CAS  PubMed  Google Scholar 

  31. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43–57. PubMed.

    PubMed  Google Scholar 

  32. Sherman A, Ter-Pogossian M. Lymph node concentration of radioactive colloidal gold following interstitial injection. Cancer. 1953;6:1238–40. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  33. Nawaz K, Hamad MM, Sedek S, Awdeh M, Eklof B, Abdel-Dayem HM. Dynamic lymph flow imaging in lymphedema: normal and abnormal patterns. Clin Nucl Med. 1986;11:653–8. PubMedCrossRef.

    Article  CAS  PubMed  Google Scholar 

  34. Werner GT, Scheck R, Kaiserling E. Magnetic resonance imaging of peripheral lymphedema. Lymphology. 1998;31:34–6. PubMed.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgement

I acknowledge Dr. Leela Praveen Kumar for helping me in bringing out the chapter succesfully.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gurusamy Manokaran MS, MCh .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Manokaran, G. (2018). Clinical Overview: Diagnosis and Management. In: Lee, BB., Rockson, S., Bergan, J. (eds) Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-319-52423-8_68

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52423-8_68

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52421-4

  • Online ISBN: 978-3-319-52423-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics